Abbott
Enhancing the Quality of Life

It is estimated that up to 28 million people in Europe live with some form of chronic pain that lasts for more than three months, and up to 8 million suffer from pain that is disabling. The sedentary lifestyles and an increase in obesity are partly to blame for this situation. And for the ageing population, this problem is further exacerbated, as older people more likely to suffer more and sometimes undergo long-term conditions such as arthritis and rheumatism.

Nevertheless, everyone wants the best for themselves to live healthier and overcome chronic pain! Abbott aims to empower patients in doing just that.

Since its inception in 1888 to this day, the company is carrying the legacy of Dr. Wallace C. Abbott, who believed that health is the key to life “because, at our healthiest, we can achieve anything!” Driven by the founder’s dream of helping people get healthier, Abbott has been at the forefront of therapeutic technology. Today, under the leadership of its president and CEO, Robert Ford, the company thoughtfully and passionately translates science into effective therapies that help people live life to the fullest. It is a global leader in the development of chronic pain therapy solutions and the only medical device manufacturer in the world to offer radiofrequency ablation (RFA) and spinal cord stimulation (SCS) therapy solutions, including BurstDR stimulation and stimulation of the dorsal root ganglion (DRG) for the treatment of chronic pain.

Behind the scenes, the company partners with healthcare providers and research experts to develop innovative technologies and deliver therapies that are safe and effective. Backed by cutting-edge manufacturing facilities spanning more than four continents, several sales and distribution offices across the world, and other offices, the company is helping millions of people worldwide to alleviate their physical and emotional toll from both chronic pains and movement disorders.

The company partners with healthcare providers and research experts to develop innovative technologies and deliver therapies that are not only safe but effective as well

Without proper care, chronic pain can become an extremely limiting obstacle in people’s lives. The long journey from one back surgery to the next, not to mention the financial and emotional pressure, can be very frustrating. Abbott helps patients to avoid all these challenges by enabling them to get a better understanding of their symptoms. The company not only helps them find the right doctor for their specific conditions but also pinpoints the right treatment as per their individual requirements.

Abbott’s extensive range of pain management technologies includes industry-leading neurostimulation solutions designed to help patients achieve the control and find the control they need. For instance, the company’s Proclaim Elite Recharge-Free spinal cord stimulation (SCS) system significantly improves the patients’ ability to perform everyday activities, while reducing the impact of chronic pain. The Proclaim Elite SCS system delivers two types of spinal cord stimulation therapy: the revolutionary BurstDR stimulation, as well traditional tonic stimulation. The system includes a small device called an implantable pulse generator (IPG) that’s implanted in the body along with thin, insulated wires called leads. When the system is turned on, the generator sends mild electrical pulses through the leads to nerves along the patients’ spinal cord to reduce the level of pain they feel.

This is but one among many other treatment solutions that Abbott brings to the table. Continuing on its path of innovation, the company is also integrating AI and mobile technologies to make pain management all the more easier for patients. As the company believes, there is no one-size-fits-all approach, and every patient has their own requirements. Thus, in order to meet their evolving needs, Abbott will keep on improving its stimulation therapies and help ease the burden of a growing number of individuals suffering from chronic pain and movement disorders.